Rocket Pharmaceuticals Announces Positive Updates from Phase

Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022

Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , America , Jessie Yeung , Kevin Giordano , Gaurav Shah , Heart Failure Society Of America , York Heart Association , Corporate Communications , York Health Association , Nasdaq , Rocket Pharmaceuticals Inc , New York Health Association , Disease Trial , Heart Failure Society , Annual Scientific Meeting , Danon Disease , Chief Executive Officer , New York Heart Association , Kansas City Cardiomyopathy Questionnaire , First Pediatric Cardiomyopathy Gene Therapy Trial , Extended Results , City Cardiomyopathy Questionnaire , Rocket Pharmaceuticals , Fanconi Anemia , Leukocyte Adhesion Deficiency I , Pyruvate Kinase Deficiency , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Investor Relations , Corporate Finance ,